The investigation has determined that a non-reproducible, higher than expected vitros bhcg result was obtained from a single patient sample on a vitros eciq immunodiagnostic system.The definitive assignable cause could not be determined, however, based on condition codes indicating the lis and vitros system were not communicating, and multiple condition codes for sample mismatch and program issues, pre-analytical sample mix up cannot be ruled out as contributing to the event, although this could not be confirmed.Based on historical quality control results and vitros bhcg within-run precision testing, there was no indication the vitros bhcg reagent or the vitros eciq system malfunctioned.Additionally, it was unknown if the affected patient sample was centrifuged according to the sample device manufacturer¿s recommendations, therefore, improper pre-analytical sample processing cannot be ruled out as contributing to the event.It is possible that cellular debris, due to poor sample preparation, was present in the affected samples, although this could not be confirmed.A definitive assignable cause for the event could not be determined.
|
A customer obtained a non-reproducible, higher than expected, vitros bhcg result from a single patient sample when processed on a vitros eciq immunodiagnostic system.Patient sample result of 79.1 miu/ml versus < 2.39 miu/ml.Biased results of the direction and magnitude observed may lead to inappropriate physician action.The non-reproducible, higher than expected vitros bhcg results was not reported outside of the laboratory and there was no report of actual patient harm as a result of this event.(b)(4).
|